EDAP LT.02 SHOCK WAVE LITHOTRIPTER

FDA Premarket Approval P880042 S002

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for a new model lithotripter, to be manufactured at the vaulx-en-velin (france) facility.

DeviceEDAP LT.02 SHOCK WAVE LITHOTRIPTER
Generic NameLithotriptor, Extracorporeal Shock-wave, Urological
ApplicantEDAP INTERNATIONAL CORP.
Date Received1995-05-19
Decision Date1996-12-18
PMAP880042
SupplementS002
Product CodeLNS 
Advisory CommitteeGastroenterology/Urology
Supplement TypeNormal 180 Day Track
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address EDAP INTERNATIONAL CORP. 179 Sidney St. cambridge, MA 02139

Supplemental Filings

Supplement NumberDateSupplement Type
P880042Original Filing
S002 1995-05-19 Normal 180 Day Track
S001 1994-02-14 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.